{"id":4370,"date":"2020-08-26T09:19:53","date_gmt":"2020-08-26T09:19:53","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/anti-dengue-performance-panel\/"},"modified":"2021-01-08T11:29:04","modified_gmt":"2021-01-08T11:29:04","slug":"anti-dengue-performance-panel","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/anti-dengue-performance-panel\/","title":{"rendered":"Anti-dengue performance panel"},"content":{"rendered":"
The first commercially available Anti-Dengue Mixed Titer Performance Panel has been launched by SeraCare. It is designed to help blood donor collection facilities, diagnostics manufacturers and clinical laboratories evaluate and troubleshoot their anti-dengue virus assays. The new performance panel is derived from undiluted, unpreserved human plasma specimens, with 21 members representing a wide range of reactivity for anti-dengue IgM and IgG antibodies, from negative to strongly positive. Panel members include samples from individuals with recent and past infection by all four dengue viruses (DENV-1 through DENV-4).
\n
\nSupplier:<\/strong> SeraCare Life Sciences
\nWebsite:<\/strong> <\/a><\/p>\n